ロード中...
Perspective: cancer vaccines in the era of immune checkpoint blockade
Current excitement about cancer immunotherapy is the result of unprecedented clinical impact from immune checkpoint inhibitors, particularly those that target programmed death (PD)-1 and PD-ligand (L)-1. Numerous other immunotherapeutics are also finding their way into the clinic either alone or in...
保存先:
| 出版年: | Mamm Genome |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267701/ https://ncbi.nlm.nih.gov/pubmed/30446791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00335-018-9786-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|